Stay updated on Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision (v3.4.2) was added to the record history, and the previous notices about government funding and revision v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check21 days agoChange DetectedThe page history adds a site-wide Notice about a lapse in government funding and a new release version (v3.4.1), replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedThe history page now includes a glossary toggle and color-coded diffs (green for additions, red for deletions). It also adds a No FEAR Act Data section and a v3.4.0 revision note.SummaryDifference0.9%

- Check42 days agoChange DetectedMinor site revision updates: Revision: v3.3.4 added and Revision: v3.3.3 removed; these changes do not affect trial data or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedA new history entry dated 2025-12-24 adds Contacts/Locations and Study Status (with version 37 appearing on 2025-12-22); the entry from 2025-11-28 was removed.SummaryDifference0.3%

- Check64 days agoChange DetectedFooter now lists Revision: v3.3.3; the HHS Vulnerability Disclosure section and Revision: v3.3.2 have been removed.SummaryDifference0.1%

Stay in the know with updates to Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.